Cogent Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cogent Biosciences, Inc. (COGT) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.100.050.260.220.240.040.08
Short-Term Investments0.190.210.120.000.000.000.00
Cash & Short-Term Investments0.290.270.260.220.240.040.08
Accounts Receivable0.000.000.000.000.000.000.00
Inventory0.000.000.000.000.000.000.00
Other Current Assets0.010.010.000.000.000.000.00
Total Current Assets0.300.270.260.220.240.040.08
Non-Current Assets
Property, Plant & Equipment (Net)0.030.030.030.000.000.010.00
Long-Term Investments0.000.010.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.000.000.00
Total Non-Current Assets0.030.040.040.010.010.010.00
Total Assets0.330.310.300.230.250.050.09
Current Liabilities
Accounts Payable0.010.010.020.000.010.010.00
Short-Term Debt0.000.000.000.000.000.000.00
Accrued Liabilities0.040.030.020.010.000.000.00
Deferred Revenue0.000.000.000.000.000.000.00
Other Current Liabilities0.040.000.000.000.010.000.00
Total Current Liabilities0.060.040.030.020.010.010.02
Non-Current Liabilities
Long-Term Debt0.020.020.020.000.000.000.00
Other Non-Current Liabilities0.000.000.000.000.010.000.00
Total Non-Current Liabilities0.020.020.020.000.000.000.00
Total Liabilities0.070.060.050.020.020.020.03
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-0.86-0.60-0.41-0.27-0.20-0.12-0.09
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.00
Additional Paid-in Capital1.000.800.600.400.320.160.15
Shares Outstanding0.110.090.070.040.000.000.00
Total Stockholders' Equity0.260.260.260.210.230.030.06
Total Liabilities & Equity0.330.310.300.230.250.050.09